REQUEST A DEMO
Total
USD $0.00
Search more companies

Innocare Pharma Limited (诺诚健华医药有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Innocare Pharma Limited Profile Updated: April 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Innocare Pharma Limited (诺诚健华医药有限公司) is based in China. The head office is in Beijing. It operates in the Pharmaceutical and Medicine Manufacturing industry. Innocare Pharma Limited (诺诚健华医药有限公司) was incorporated on November 03, 2015. It currently has a total number of 939 (2022) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 135.27% in 2025. A growth of 15.05% was recorded in its total assets.

Headquarters
Building 8, Yard 8, Life Garden Road, Zhongguancun Life Science Park, Changping District, Beijing
Beijing; Beijing; Postal Code: 102206

Contact Details: Purchase the Innocare Pharma Limited (诺诚健华医药有限公司) report to view the information.

Website: http://www.innocarepharma.com

Basic Information
Total Employees:
Purchase the Innocare Pharma Limited (诺诚健华医药有限公司) report to view the information.
Outstanding Shares:
Purchase the Innocare Pharma Limited (诺诚健华医药有限公司) report to view the information.
Registered Capital:
Purchase the Innocare Pharma Limited (诺诚健华医药有限公司) report to view the information.
Financial Auditors:
Purchase the Innocare Pharma Limited (诺诚健华医药有限公司) report to view the information.
Incorporation Date:
November 03, 2015
Key Executives
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive Director
Ownership Details
Purchase this report to view the information.
0.53%
Subsidiaries
Beijing Nuocheng Jianhua Pharmaceutical Technology Co., Ltd.
100%
InnoCare Pharma Australia Pty Ltd
100%
InnoCare Pharma Inc.
100%
Company Performance
Financial values in the chart are available after Innocare Pharma Limited (诺诚健华医药有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
135.27%
Total Operating Revenue
146.76%
Operating Profit
N/A
Net Profit/Loss for the Period
N/A
Total Assets
15.05%
Total Equity
14.87%
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
-1.93%
Quick Ratio
-1.65%
Cash Ratio
-0.84%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?